Structure of cerebral arterioles in mice deficient in expression of the gene for endothelial nitric oxide synthase

Circulation Research
Gary L BaumbachFrank M Faraci

Abstract

We examined effects of pharmacological inhibition of nitric oxide synthase (NOS) and genetic deficiency of the endothelial isoform of NOS (eNOS) on structure and mechanics of cerebral arterioles. We measured pressure, diameter, and cross-sectional area (CSA) of the vessel wall (histologically) in maximally dilated cerebral arterioles in mice that were untreated or treated for 3 months with the NOS inhibitor, N(G)-nitro-L-arginine methyl ester (L-NAME; 10 mg/kg per day in drinking water). Treatment with L-NAME increased systemic arterial mean pressure (SAP; 143+/-4 versus 121+/-4 mm Hg, P<0.05) and CSA (437+/-27 versus 310+/-34 microm2, P<0.05). These findings suggest that hypertension induced in mice by NOS inhibition is accompanied by hypertrophy of cerebral arterioles. To determine the role of the eNOS isoform in regulation of cerebral vascular growth, we examined mice with targeted disruption of one (heterozygous) or both (homozygous) genes encoding eNOS. Wild-type littermates served as controls. SAP and CSA were significantly increased in homozygous (SAP, 141+/-5 versus 122+/-3 mm Hg in wild-type mice, P<0.05; CSA, 410+/-18 versus 306+/-15 microm2 in wild-type mice, P<0.05), but not in heterozygous (SAP, 135+/-4 mm Hg; CSA,...Continue Reading

References

Mar 1, 1990·The American Journal of Physiology·A BobikS Grinpukel
Jan 1, 1989·British Journal of Clinical Pharmacology·W FischliJ P Clozel
Aug 1, 1989·Atherosclerosis·Y HirataF Marumo
Jun 1, 1989·Hypertension·G L Baumbach, D D Heistad
Nov 1, 1988·Hypertension·C A Eccleston-Joyner, S D Gray
Nov 12, 1996·Proceedings of the National Academy of Sciences of the United States of America·E G SheselyO Smithies
Mar 21, 1998·The Journal of Clinical Investigation·R D RudicW C Sessa
Mar 5, 1998·The American Journal of Physiology·F M FaraciD D Heistad
Mar 10, 2000·American Journal of Physiology. Heart and Circulatory Physiology·C M BrophyJ S Pollock
Jul 18, 2000·American Journal of Physiology. Cell Physiology·L SandirasegaraneM Kester
Nov 16, 2002·Circulation Research·Gary L BaumbachSteven R Lentz
Jan 4, 2003·Hypertension·Gary L BaumbachFrank M Faraci
Mar 24, 2004·Trends in Genetics : TIG·Nobuyuki Takahashi, Oliver Smithies

❮ Previous
Next ❯

Citations

Feb 19, 2011·Current Hypertension Reports·Cristina SierraErnesto L Schiffrin
Sep 8, 2007·Antioxidants & Redox Signaling·Sanjana Dayal, Steven R Lentz
May 24, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Siu-Lung Chan, Marilyn J Cipolla
Mar 15, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Xinzhi PengMary Susan Burnett
Sep 20, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Virginie BolducEric Thorin
Jan 24, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Virginie BolducEric Thorin
Feb 22, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Frank M Faraci
May 9, 2012·Anatomy Research International·Mawadda AlnaeeliConstance Tom Noguchi
Oct 3, 2008·Neuropsychiatric Disease and Treatment·Bernhard J Schaller
Sep 14, 2007·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Robert D RoghairFred S Lamb
Oct 24, 2015·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Stephana CarelliAlfredo Gorio
Aug 14, 2008·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Atticus H Hainsworth, Hugh S Markus
Mar 19, 2016·Cellular and Molecular Neurobiology·T Michael De Silva, Frank M Faraci
Apr 18, 2006·Pharmacology & Therapeutics·Alyson A MillerChristopher G Sobey
Apr 11, 2013·International Journal of Hypertension·Siu-Lung Chan, Gary L Baumbach
Jul 27, 2010·Journal of Biomechanics·Samantha M SteelmanJay D Humphrey
Oct 27, 2011·Neuroscience Letters·Gerburg Keilhoff
Jun 5, 2008·Cell Metabolism·Costantino Iadecola, Robin L Davisson
Dec 1, 2017·International Journal of Molecular Sciences·Sean P Didion
Feb 9, 2008·Hypertension·Marilyn J CipollaJulie A Godfrey
Nov 11, 2006·Circulation Research·Frank M Faraci
Feb 6, 2017·Circulation Research·Xiaoming HuFrank M Faraci
Jan 18, 2005·Stroke; a Journal of Cerebral Circulation·Frank M Faraci
Jun 10, 2006·Stroke; a Journal of Cerebral Circulation·Gary L BaumbachFrank M Faraci
Dec 25, 2004·Stroke; a Journal of Cerebral Circulation·Frank M Faraci
May 25, 2007·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Sharyn M FitzgeraldRoger G Evans
Mar 19, 2009·Pharmacological Reviews·Noboru TodaTomio Okamura
Jun 28, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Jean-Marc BugnicourtJean-Marc Chillon
May 21, 2019·Journal of Neurochemistry·Chanawee HirunpattarasilpFelipe Freitas
Jun 25, 2013·American Journal of Physiology. Heart and Circulatory Physiology·Virginie BolducEric Thorin
Feb 14, 2021·Proceedings of the National Academy of Sciences of the United States of America·Petra KameritschHeike Beck
Mar 13, 2021·The American Journal of Pathology·Francesca-Fang LiaoXing-Lin Tan
Oct 30, 2021·American Journal of Physiology. Heart and Circulatory Physiology·William E HughesAndreas M Beyer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.